Global Parkinson's Disease Market Research - Frontier Pharma - JSB Market Research

1
Global Parkinson's Disease Market Research -
Frontier Pharma
To buy this Report Visit http//www.jsbmarketresea
rch.com
2
Buy 2 Reports Get 1 Free Click Here For
Special Discount Offer On Infiniti Research
Limited http//www.jsbmarketresearch.com/publishe
r/infiniti-research-limited For more inquiries,
contact at 91 - 998 729 5242 /contact_at_jsbmarket
research.com
To buy this Report Visit http//www.jsbmarketresea
rch.com
3
SummaryLarge Degree of Innovation
in Parkinsons Disease Pipeline

• The Parkinsons disease (PD) pipeline currently
  has 302 products in active development across all
  stages, but a stark contrast between the
  mechanisms of action employed in the current
  market and the pipeline is evident. Where the
  market relies on symptomatic treatments that
  target neuromodulatory receptors, the pipeline
  shows a diverse range of neuroprotective
  therapies targeting dysfunctional disease
  processes. This diversity is partially due to the
  presence of 90 first-in-class products, which
  accounts for 37 of the overall pipeline
  therapies that disclosed their target. In an
  industry, market and development landscape that
  favors first-in-class over non-first-in-class
  development in many ways, such as through faster
  approval or greater revenue, this finding has
  strategic implications for a wide array of market
  participants, both large and small.

4
Alignment of First-in-Class Molecular Target
with Disease Processes and Genetics

• PD is a complex and multifaceted disease with a
  complex interplay between different pathological
  processes. Enormous research efforts and
  significant technological advances have furthered
  knowledge of the neuroanatomy of the basal
  ganglia and of the fundamental processes
  underlying neurodegeneration, helped by the
  ongoing identification of susceptibility genes
  and causative genes in familial PD. Although the
  exact mechanisms that initiate onset remain
  unclear, these insights have been translated into
  the pool of novel therapeutic targets, which may
  potentially become disease-modifying therapies by
  aligning to the disease processes and some
  genetic determinants of PD.
•  
• GBI Researchs proprietary analysis showed
  substantial variation in how well the functional
  roles of PD first-in-class targets align to the
  pathophysiology of PD. Further in-depth analysis
  identified the most promising first-in-class
  targets based on various scientific and clinical
  parameters. Examining scientific and clinical
  data of promising first-in-class targets showed
  that first-in-class status is not, in its own
  right, enough for a successful product however,
  the first-in-class products substantiated by
  scientific and clinical evidence will be exciting
  future prospects with the potential to transform
  the global parkinson's disease market.
•  

5
Scope

• The report analyzes innovation in PD in the
  context of the overall pipeline and current
  market landscape. It also analyzes the deals
  landscape surrounding first-in-class products and
  pinpoints in-licensing opportunities. The report
  includes -
• - A brief introduction to PD, including symptoms,
  pathophysiology, and an overview of
  pharmacotherapy and treatment algorithms
• - Coverage of the changing molecular target
  landscape and particular points of innovation in
  the pipeline
• - A comprehensive review of the pipeline for
  first-in-class therapies, analyzed by stage of
  development, molecule type and molecular target
• - Identification and assessment of first-in-class
  molecular targets with a particular focus on
  early-stage programs of which clinical utility
  has yet to be evaluated, as well as literature
  reviews of novel molecular targets
• Industry-wide analysis of first-in-class deals
  compared to non-first-in-class deals
•  Check Full Report on
• http//www.jsbmarketresearch.com/healthcare-medica
  l/r-frontier-pharma-parkinsons-disease-identifying
  -and-commercializing-first-in-class-innovation-151
  420

6
Reasons to buy

• The report will enable business development and
  enable marketing executives to strategize their
  product launches by allowing them to -
• - Understand the focal shifts in molecular
  targets in the PD pipeline
• - Understand the distribution of pipeline
  programs by phase of development, molecule type
  and molecular target
• - Access a scientific and clinical analysis of
  first-in-class developmental programs for PD,
  benchmarked against non-first-in-class targets
• - Assess the valuations of licensed and
  co-developed PD treatments
•   

7
Table of Contents
Global Parkinson's Disease Market Research -
Frontier Pharma
List of Tables
Executive Summary
Clinical and Commercial Landscape
The Case for Innovation
8
Price Chart

• Report Name Global Parkinson's Disease Market
  Research - Frontier Pharma
• Product Price

License Type Price
PDF 6295.5
Site License 11891.5
Enterprise Wide License 20985
Click Here
To View OR Purchase Report
9
Related Market Research Report

• Oxidative Stress Assay Market by Product
  (Consumables, Instruments, Services), Test Type
  (Indirect, Enzyme-based, Reactive Oxygen Species
  (ROS)-based), Technology (ELISA, Chromatography,
  Flow Cytometry), End Users - Global Forecast to
  2020
• European Microscopy Market by Product (Optical
  (Fluorescence, Super-Resolution), Confocal,
  Electron (Transmission), Scanning (AFM)),
  Application (Semiconductor, Life Science,
  Nanotechnology), End User (Academic Institute,
  Industries) - Forecast to 2020
• Immunoassay Market by Technology (ELISA,
  Fluorescence, Colorimetric, Chemiluminescence,
  Rapid Test, Western Blot, ELISPOT, PCR),
  Application (Infectious Disease, Endocrinology,
  Cardiology, Oncology, Hematology), End User -
  Global Forecast to 2019
• Genotyping Market by Technology (Polymerase Chain
  Reaction, Sequencing, Microarray,
  Electrophoresis, MALDI_TOF), Application
  (Pharmacogenomics, Diagnostic Research, Animal
  Genetics, Agricultural Biotechnology) by
  Products - Global Forecast to 2020
• Bioburden Testing Market by Product Instrument
  (PCR, Microscopes), Consumables (Kit,
  Reagent), Test (Aerobic, Anaerobic, Fungi,
  Spore), Application (Raw Material, In-process)
  End User (Pharmaceutical, Biotechnology, CMO) -
  Forecast to 2019
• EMR/EHR Market in the US 2015-2019
• Global Capsule Endoscopes Market 2015-2019
• Global Diabetic Retinopathy Market 2015-2019
• Electrophoresis Market by Product (1D 2D Gel
  Electrophoresis, Agarose Polyacrylamide Gel,
  Capillary Electrophoresis, Isoelectric Focusing,
  Isotachophoresis, CZE, CGE, MEKC, Reagents,
  Informatics), Application End User - Global
  Forecast to 2020
• Healthcare and Medical Market Research

10
About JSB Market Research

• JSB market research is amongst the best online
  market research companies providing the most
  significant online database of various industry
  research reports and services. This online portal
  contains high-quality market research reports
  with well-researched content on a wide range of
  industries. We specialize in providing the best
  market research reports for various industries.
• Also JSBs database consists of detailed
  insights of the leading players in the global
  market, products and trends also find latest
  updates on global conference events.

11
Contact Us

• Support General Inquiries
• Mail support_at_jsbmarketresearch.com
  91 - 998 729 5242
• Billing Support
• Mail billing_at_jsbmarketresearch.com
  022-27564963
• Website http//www.jsbmarketresearch.com